ZIM
DTIL icon

Zacks Investment Management’s Precision BioSciences DTIL Stock Holding History

Zacks Investment Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,182
Closed -$46K – 614
2022
Q3 		$46K Buy
+1,182
New +$56.2K ﹤0.01% 563

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Zacks Investment Management's DTIL Position: Q4 2022 in Review

Zacks Investment Management sold out of Precision BioSciences (DTIL) in Q4 2022, closing a stake of 1,182 shares — an estimated $46K sold.

Zacks Investment Management first reported a position in DTIL in Q3 2022 and held it in 1 quarter. The position peaked at $46K in Q3 2022. 100 funds tracked by Wall St. Rank hold DTIL as of Q4 2022.

  • Zacks Investment Management reported no remaining Precision BioSciences position as of Q4 2022 after selling out during the quarter.
  • Zacks Investment Management sold 1,182 Precision BioSciences shares in Q4 2022, an estimated $46K.
  • Zacks Investment Management first reported a position in Precision BioSciences in Q3 2022 and held it in 1 quarter.
  • Zacks Investment Management's Precision BioSciences position peaked at $46K in Q3 2022.
  • 100 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2022.

Based on Zacks Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.